The Chromatin immunoprecipitation (ChIP) Sequencing Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Chromatin immunoprecipitation (ChIP) Sequencing Market?
The market size of the chromatin immunoprecipitation (ChIP) sequencing has seen rapid expansion lately. It increased from $13.89 billion in 2024 to $15.6 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 12.3%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Chromatin immunoprecipitation (ChIP) Sequencing Industry?
The Chromatin immunoprecipitation (ChIP) Sequencing Global Market Report 2025 projects that by 2029, the market size will be $25.37 billion, growing at a compound annual growth rate (CAGR) of 12.9%.
Download Your Free Sample of the 2025 Chromatin immunoprecipitation (ChIP) Sequencing Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Chromatin immunoprecipitation (ChIP) Sequencing Market?
The key drivers in the chromatin immunoprecipitation (chip) sequencing market are:
• Increased industry investment and competition
• Rising clinical adoption and diagnostic applications
• Growing demand for biomarker discovery
• Rapid advancements in bioinformatics tools.
Global Market Segmentation: Identifying Major Chromatin immunoprecipitation (ChIP) Sequencing Industry Segments
The chromatin immunoprecipitation (ChIP) sequencing market covered in this report is segmented –
1) By Type: DNase-Sequencing, FAIRE-Sequencing
2) By Technology: Targeted Sequencing And Re-Sequencing, Whole Genome Sequencing And Whole Exome Sequencing
3) By Workflow: Pre-Sequencing, Sequencing, Data Analysis
4) By Application: Consumables And Reagents, Service, Other Applications
5) By End-User: Academic Research Institutes, Clinical Research Institutes, Hospitals And Clinics, Pharmaceuticals And Biotechnology Companies, Other End Users
Pre-order the 2025 Chromatin immunoprecipitation (ChIP) Sequencing Global Market Report for Fast Delivery & Comprehensive Insights!
What are the Emerging Trends Shaping the Future of the Chromatin immunoprecipitation (ChIP) Sequencing Market?
The key trends in the chromatin immunoprecipitation (chip) sequencing market are:
• Clinical translation and diagnostic applications are emerging trends in the market.
• There is a growing focus on histone modification techniques.
• Novel research areas are increasingly using ChIP sequencing.
• There are advancements in sample preparation and multi-omics integration underway.
Who Are the Top Competitors & Leading Players in the Chromatin immunoprecipitation (ChIP) Sequencing Market?
Major companies in the chromatin immunoprecipitation (chip) sequencing market are:
• F. Hoffmann La Roche Ltd.
• Merck KGaA
• Thermo Fisher Scientific Inc.
• Becton Dickinson and Co.
• Eurofins Scientific SE
• Agilent Technologies Inc.
• Illumina Inc.
• PerkinElmer Inc.
• Bio-Rad Laboratories Inc.
• Qiagen N.V.
• Bio-Techne Corp.
• BGI Genomics Co. Ltd.
• Promega Corporation
• GenScript Biotech Corporation
• Abcam PLC
• BioLegend Inc.
• Hamilton Co.
• Takara Bio Inc.
• Novogene Co. Ltd.
• Oxford Nanopore Technologies PLC
• Porvair Sciences Ltd.
• Creative Biolabs Inc.
• Cell Signaling Technology Inc.
• GENEWIZ Inc.
• Zymo Research Corporation
• CD Genomics
• Active Motif Inc.
• Psomagen Inc.
• EpiCypher Inc.
Regional Dominance: Which Area Leads the Global Chromatin immunoprecipitation (ChIP) Sequencing Market?
North America was the largest region in the chromatin immunoprecipitation (ChIP) sequencing market in 2024
